Glass Health vs Tempus AI
A detailed comparison to help you choose between Glass Health and Tempus AI.
🏆
Verdict: Tempus AI wins
Tempus AI scores 4.1/5, edging out Glass Health at 3.7/5. Cancer centers, molecular labs and health systems building precision-oncology programs that need sequencing, interpretation and data products under one roof — and pharma partners buying real-world data access.
Glass Health AI for clinical decision support | Tempus AI AI for precision medicine and clinical genomics | |
|---|---|---|
| Rating | 3.7 (1 review) | 4.1 (1 review) |
| Pricing Model | freemium | paid |
| Starting Price | Free tier available | From $1000/mo |
| Best For | Physicians, residents and nurse practitioners who want cited differential reasoning and plan drafting alongside an ambient scribe — especially solo users comfortable with the terms, or practices willing to sign the BAA and buy Max for EHR integration. | Cancer centers, molecular labs and health systems building precision-oncology programs that need sequencing, interpretation and data products under one roof — and pharma partners buying real-world data access. |
| Free Tier | ||
| API Access | ||
| Team Features | ||
| Open Source | ||
| Tags | free tier | ssoteam features |
| Visit Glass Health → | Visit Tempus AI → |
Glass Health
Pros
- + Differential diagnosis with per-item reasoning and openable citations — in my testing it surfaced considerations I had missed, not paraphrases of my prompt
- + Real-time clinical prompts (follow-up questions, differential ideas) appeared mid-encounter while the note drafted in the background
- + Public pricing with a genuine free tier: $0 / $20 / $90 / $200 per month at time of writing, no sales call required
- + Independent evidence exists — two studies beating ChatGPT on defined tasks, plus the Harvard-Stanford ARISE NOHARM benchmark covered by Forbes (March 2026)
- + Specialty modes and 62+ scribing languages make it usable outside US-English primary care
Cons
- - Individual Terms of Service authorize training models on the patient data you enter and allow sale of de-identified data; the BAA is opt-in, not automatic
- - Lite and Starter are ad-supported — sponsorships appear inside a clinical tool
- - EHR integration (Athena, Epic, eCW, Elation) is Max-only at $200/month, gating the main workflow payoff
- - Usage caps on lower tiers are described only as "limited" or "standard" with no published numbers
- - No prospective patient-outcomes study; it is decision support, not a diagnostic device, and remains clinician-verified
Tempus AI
Pros
- + FY2025 revenue of $1.3B with 126% net revenue retention and >$1.1B remaining contract value — verifiable public-company financials, not marketing claims
- + Complete assay portfolio in one relationship: xT/xR comprehensive profiling, xF+ liquid biopsy, MRD monitoring, Ambry hereditary testing and OneOme pharmacogenomics (national launch July 2026)
- + Tempus One answered voice queries against the patient's own clinical and molecular profile in my testing, with report citations instead of generic text
- + Paige Predict extends the platform into digital pathology — 123 biomarkers predicted from standard H&E slides across 16 cancer types (vendor-published validation)
- + Trial matching is built into the report workflow, which is the practical bottleneck for oncology coordinators
Cons
- - No self-serve access, no trial, and no published pricing of any kind — the $1,000 entry figure floating around listings could not be verified
- - Oncology-first scope; primary care and non-oncology specialties have little reason to engage
- - Still net-loss-making (-$245.0M in 2025), and the portfolio is stitched from four recent acquisitions (Ambry, Paige, OneOme, Deep 6)
- - Model-performance and data-library claims are company-published; independent third-party validation is thinner than the press-release volume suggests
- - Enterprise sales motion means long procurement cycles for health systems
Frequently Asked Questions
Which is better, Glass Health or Tempus AI?▼
Tempus AI scores higher at 4.1/5 vs 3.7/5 for Glass Health, making it the better-rated option in our comparison.
What is the difference between Glass Health and Tempus AI?▼
Glass Health: Glass Health is a clinical AI assistant for doctors and other clinicians, giving answers and decision support grounded in current medical evidence to help with diagnosis and patient care. Tempus AI: Tempus AI runs clinical and genomic sequencing and builds the diagnostics and data products used in precision oncology and other specialties.
Is Glass Health or Tempus AI more affordable?▼
Glass Health starts at €0/mo, Tempus AI starts at €1000/mo. Check the comparison table above for current pricing.
Stay in the loop
Get weekly updates on the best new AI tools, deals, and comparisons.
No spam. Unsubscribe anytime.